This is a StreetInsider.com Premium Only Page

(ARGX) – Trader Talk

Mar 21, 2024 09:32 AM Guggenheim reiterates Buy rating on Tourmaline Bio (TRML), "news is likely to increase investors' perceived risk"

Mar 21, 2024 07:23 AM Roche falls, Argenx (ARGX) gains after Chugai's Enspryng drug for myasthenia gravis fails

Dec 20, 2023 07:47 AM

Dec 20, 2023 07:40 AM

Dec 20, 2021 06:07 AM

Aug 19, 2020 08:38 AM

Aug 19, 2020 07:44 AM

May 5, 2020 07:10 AM